7 terminated. 7 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 7 | Terminated 7 |
Follow Congenital Abnormalities: new trials by email Literature Review of Congenital Abnormalities trials Research Report on Congenital Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel Strategies to Improve Immunomodulation and Non-invasive Clinical Monitoring in VCA IL-2 - Amputation, Traumatic, Amputation;Traumatic;Old | Early Phase 1 | Terminated | Brigham and Women's Hospital | 2 | 2017-10-17 | 2021-07-28 |
| 68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors Computed Tomography, Gallium Ga 68-Edotreotide, Positron Emission Tomography - Meningioma, Metastatic Well Differentiated Neuroendocrine Neoplasm | Early Phase 1 | Terminated | M.D. Anderson Cancer Center | 4 | 2017-05-16 | 2021-02-15 |
| GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors Replens and coconut oil - Genitourinary Abnormality, Breast Cancer Female | Early Phase 1 | Terminated | Alta Bates Summit Medical Center | 14 | 2016-11-18 | 2018-07-26 |
| Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins Simvastatin - Cavernous Angioma, Familial, Cerebral Cavernous Malformations | Early Phase 1 | Terminated | University of New Mexico | 12 | 2012-03-01 | 2024-03-12 |
| Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage HP828-101 - Skin Abnormalities | Early Phase 1 | Terminated | Healthpoint | 7 | 2010-04-01 | 2013-12-06 |
| Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease Avastin - Hemangioblastomas, Von Hippel Lindau Disease | Early Phase 1 | Terminated | Dartmouth-Hitchcock Medical Center | 1 | 2009-12-01 | 2012-05-11 |
| Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Palifermin, Fludarabine, Busulfan - Epidermolysis Bullosa | Early Phase 1 | Terminated | Columbia University | 3 | 2009-08-20 | 2021-08-17 |
von Hippel-Lindau Disease (2) · Amputation, Traumatic (1) · Dyspareunia (1) · Dysuria (1) · Epidermolysis Bullosa (1) · Epidermolysis Bullosa Dystrophica (1) · Facial Injuries (1) · Facies (1) · Hemangioblastoma (1) · Hemangioma, Cavernous, Central Nervous System (1) · Meningioma (1) · Multiple Endocrine Neoplasia Type 1 (1) · Neuroendocrine Tumors (1) · Skin Abnormalities (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Nervous System Diseases (4) · Cardiovascular Diseases (3) · Genetic Diseases, Inborn (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Vascular Tissue (3) · Vascular Diseases (3) · Abnormalities, Multiple (2) · Angiomatosis (2) · Ciliopathies (2) · Hemangioma (2) · Neurocutaneous Syndromes (2) · Pathological Conditions, Signs and Symptoms (2)
Alemtuzumab (1) · Bevacizumab (1) · Busulfan (1) · Coconut Oil (1) · Fibroblast Growth Factor 7 (1) · Interleukin-2 (1) · Lorazepam (1) · Magnetic Resonance Spectroscopy (1) · Replens (1) · Simvastatin (1) · Tacrolimus (1) · fludarabine (1) · fludarabine phosphate (1) · gallium Ga 68 dotatate (1)
Alta Bates Summit Medical Center (1) · Brigham and Women's Hospital (1) · Columbia University (1) · Dartmouth-Hitchcock Medical Center (1) · Healthpoint (1) · M.D. Anderson Cancer Center (1) · University of New Mexico (1)
United States (7)
Angela Christiano, PhD (1) · Blaine Hart, MD (1) · Bohdan Pomahac, MD (1) · Herbert B Slade, MD (1) · Homer A Macapinlac, MD (1) · J Marc Pipas, MD (1) · Leslie A Morrison, MD (1) · Neeta Nayak, MD (1) · Uma Suryadevara, MD (1)
U54NS065705 (1)